Skip Navigation



JAC Advance Access published online on July 26, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl302
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
58/3/669    most recent
dkl302v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Loli, A.
Right arrow Articles by Miriagou, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loli, A.
Right arrow Articles by Miriagou, V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Received May 26, 2006
Revised July 3, 2006
Accepted July 4, 2006

Brief report

Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1

A. Loli 1, L. S. Tzouvelekis 2, E. Tzelepi 1, A. Carattoli 3, A. C. Vatopoulos 4, P. T. Tassios 5, and V. Miriagou 1 *

1 Laboratory of Bacteriology, Institute Pasteur Hellenique, Athens, Greece
2 Laboratory of Bacteriology, Institute Pasteur Hellenique, Athens, Greece; Department of Microbiology, Medical School, University of Athens, Athens, Greece
3 Department of Infectious, Parasitic and Immunomediated Diseases, Istituto Superiore di Sanita, Rome, Italy
4 Department of Microbiology, National School of Public Health, Athens, Greece
5 Department of Microbiology, Medical School, University of Athens, Athens, Greece

* To whom correspondence should be addressed.
V. Miriagou, E-mail: miriagou{at}mail.pasteur.gr


  Abstract

Objectives: To elucidate the mechanisms responsible for the diversity of {beta}-lactam resistance phenotypes among isolates of a VIM-1-producing Klebsiella pneumoniae (VPKP) strain that is endemic in Greek hospitals.

Methods: Five VPKP clinical isolates were studied. MICs of {beta}-lactams were determined by agar dilution. PFGE of XbaI-digested genomic DNA was used for typing. Profiles of outer membrane proteins (OMPs) were determined by SDS-PAGE. Selected isolates were transformed with a plasmid encoding the Omp36K porin. {beta}-Lactamase activities were analysed by IEF and imipenem hydrolysis was assessed by spectrophotometry. VIM-1-encoding, self-transmissible plasmids were characterized by replicon typing, RFLP and hybridization with blaVIM- and IS26-specific probes. Characterization of integrons was performed by PCR, cloning and sequencing.

Results: Isolates exhibited highly similar PFGE patterns. Imipenem MICs were 2, 4, 16, 32 and 64 mg/L. The isolate with the highest imipenem MIC (Vipm-64) lacked a 36 kDa OMP. Expression of a cloned OmpK36 in this isolate reduced the imipenem MIC to susceptibility levels. Imipenem-hydrolysing activity was significantly higher in Vipm-16 as compared with the other isolates that expressed similar amounts of VIM-1. All isolates transferred {beta}-lactam resistance to Escherichia coli through conjugative, IncN plasmids that exhibited differences in the RFLP and hybridization patterns with blaVIM- and IS26-specific probes. The Vipm-16 plasmid, mediating the higher imipenem MICs among transconjugants, carried two copies of blaVIM-1. Cloning and sequencing showed In-e541-like integrons truncated at the 5'CS by insertion of IS26 elements at two different positions.

Conclusions: A VIM-1-producing strain of K. pneumoniae has evolved through OMP alterations and rearrangements in the blaVIM-1-carrying plasmid probably mediated by IS26, generating isolates with imipenem MICs ranging from susceptibility to resistance.

Keywords: K. pneumoniae; metallo-{beta}-lactamases; {beta}-lactam resistance.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Microbiol.Home page
M. Falcone, M. L. Mezzatesta, M. Perilli, C. Forcella, A. Giordano, V. Cafiso, G. Amicosante, S. Stefani, and M. Venditti
Infections with VIM-1 Metallo-{beta}-Lactamase-Producing Enterobacter cloacae and Their Correlation with Clinical Outcome
J. Clin. Microbiol., November 1, 2009; 47(11): 3514 - 3519.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
P. Giakkoupi, O. Pappa, M. Polemis, A. C. Vatopoulos, V. Miriagou, A. Zioga, C. C. Papagiannitsis, and L. S. Tzouvelekis
Emerging Klebsiella pneumoniae Isolates Coproducing KPC-2 and VIM-1 Carbapenemases
Antimicrob. Agents Chemother., September 1, 2009; 53(9): 4048 - 4050.
[Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
G. L. Daikos, P. Petrikkos, M. Psichogiou, C. Kosmidis, E. Vryonis, A. Skoutelis, K. Georgousi, L. S. Tzouvelekis, P. T. Tassios, C. Bamia, et al.
Prospective Observational Study of the Impact of VIM-1 Metallo-{beta}-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
Antimicrob. Agents Chemother., May 1, 2009; 53(5): 1868 - 1873.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. Souli, P. D. Rekatsina, Z. Chryssouli, I. Galani, H. Giamarellou, and K. Kanellakopoulou
Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo-{beta}-Lactamase-Producing Klebsiella pneumoniae Isolates?
Antimicrob. Agents Chemother., May 1, 2009; 53(5): 2133 - 2135.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
Y. Liu, B. Zhang, Q. Cao, W. Huang, L. Shen, and X. Qin
Two Clinical Strains of Klebsiella pneumoniae Carrying Plasmid-Borne blaIMP-4, blaSHV-12, and armA Isolated at a Pediatric Center in Shanghai, China
Antimicrob. Agents Chemother., April 1, 2009; 53(4): 1642 - 1644.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Loli, L. S. Tzouvelekis, D. Gianneli, E. Tzelepi, and V. Miriagou
Outbreak of Acinetobacter baumannii with Chromosomally Encoded VIM-1 Undetectable by Imipenem-EDTA Synergy Tests
Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1894 - 1896.
[Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
J. H. Wu, A. M. Wu, C. G. Tsai, X.-Y. Chang, S.-F. Tsai, and T.-S. Wu
Contribution of Fucose-Containing Capsules in Klebsiella pneumoniae to Bacterial Virulence in Mice
Experimental Biology and Medicine, January 1, 2008; 233(1): 64 - 70.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. Psichogiou, P. T. Tassios, A. Avlamis, I. Stefanou, C. Kosmidis, E. Platsouka, O. Paniara, A. Xanthaki, M. Toutouza, G. L. Daikos, et al.
Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey
J. Antimicrob. Chemother., January 1, 2008; 61(1): 59 - 63.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
C. Colinon, V. Miriagou, A. Carattoli, F. Luzzaro, and G. M. Rossolini
Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 {beta}-lactamases
J. Antimicrob. Chemother., August 1, 2007; 60(2): 258 - 262.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
A. M. Queenan and K. Bush
Carbapenemases: the Versatile {beta}-Lactamases
Clin. Microbiol. Rev., July 1, 2007; 20(3): 440 - 458.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
P. Bogaerts, T. Naas, I. Wybo, C. Bauraing, O. Soetens, D. Pierard, P. Nordmann, and Y. Glupczynski
Outbreak of Infection by Carbapenem-Resistant Acinetobacter baumannii Producing the Carbapenemase OXA-58 in Belgium
J. Clin. Microbiol., November 1, 2006; 44(11): 4189 - 4192.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.